Feng Huang Wang·2026-02-06 23:09Market Performance - The US stock market experienced a significant rebound, with the S&P 500 index recording its largest single-day gain since May 2022, rising by 1.97% to close at 6932.3 points. The Dow Jones Industrial Average also reached a historic milestone, surpassing the 50,000 points mark, closing up 2.47% at 50115.67 points [1] - Notable stock performances included Nvidia, which surged over 7%, adding more than $320 billion to its market capitalization. Other cyclical/value stocks like Caterpillar, Goldman Sachs, and JPMorgan also saw increased capital inflow, contributing to the Dow's record high [1] Technology Sector - Amazon's announcement of a capital expenditure plan of up to $200 billion for 2026 led to a decline of over 5% in its stock price, highlighting skepticism regarding AI spending in the market. Google, which previously disclosed a capital expenditure of $185 billion, also saw its stock drop by over 2% [5] - Nvidia's CEO reiterated the sustainability of large AI investments, stating that companies will continue to invest heavily in AI as long as they can achieve profitability from these investments [6] Cryptocurrency and Commodities - The market saw a rebound in risk assets, with silver prices rising nearly 10% and Bitcoin increasing by almost 12% [3] - The rebound in commodities also positively impacted the materials sector, with Century Aluminum rising by 11.80% and Hilltop Holdings increasing by 8.82% [6] Chinese Stocks - Chinese stocks continued to perform strongly, with the Nasdaq Golden Dragon China Index rising by 3.71%. Key performers included Alibaba (+3.01%), JD.com (+2.75%), and NIO (+7.23%) [7] Tesla and Renewable Energy - Tesla is reportedly evaluating options to increase its solar production capacity, including expanding its Buffalo, New York factory to 10 gigawatts and potentially building additional factories in New York, Arizona, or Idaho [8] FDA and Pharmaceutical Sector - The FDA announced plans to crack down on illegal GLP-1 drugs, which negatively impacted Hims & Hers Health, causing its stock to drop over 13% after the launch of its oral medication [9] Automotive Industry - Stellantis faced a significant decline of 23.69% in its stock price after announcing a restructuring plan that would lead to a reduction in its electric vehicle business, resulting in a loss of €22.2 billion [10]